These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1077 related items for PubMed ID: 18469305

  • 21. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
    del Moral RG, Andujar M, Ramírez C, Gómez-Morales M, Masseroli M, Aguilar M, Olmo A, Arrebola F, Guillén M, García-Chicano MJ, Nogales FF, O'Valle F.
    Am J Pathol; 1997 Dec; 151(6):1705-14. PubMed ID: 9403721
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ, Tian YC, Chen YC, Lai BC, Fang JT, Yang CW, Wu MS.
    Ren Fail; 2008 Dec; 30(3):303-6. PubMed ID: 18350450
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients.
    Stallone G, Di Paolo S, Schena A, Infante B, Grandaliano G, Battaglia M, Gesualdo L, Schena FP.
    Transplantation; 2003 Apr 15; 75(7):998-1003. PubMed ID: 12698087
    [Abstract] [Full Text] [Related]

  • 26. Prospective observational study of sirolimus as primary immunosuppression after renal transplantation.
    Pescovitz MD, Nezakatgoo N, Lorber MI, Nashan B, Tedesco-Silva H, Kasiske BL, de la Cruz FJ, Russ G, Campistol J, Keown PA, International Sirolimus Study Group.
    Transplantation; 2009 Oct 27; 88(8):1010-8. PubMed ID: 19855247
    [Abstract] [Full Text] [Related]

  • 27. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 27; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats.
    Deniz H, Oğütmen B, Cakalağaoğlu F, Tuğlular S, Ozener C, Akoğlu E.
    Transplant Proc; 2006 Mar 27; 38(2):483-6. PubMed ID: 16549154
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L.
    Transpl Immunol; 2009 Jan 27; 20(3):139-42. PubMed ID: 18834941
    [Abstract] [Full Text] [Related]

  • 31. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
    Reis F, Parada B, Teixeira de Lemos E, Garrido P, Dias A, Piloto N, Baptista S, Sereno J, Eufrásio P, Costa E, Rocha-Pereira P, Santos-Silva A, Figueiredo A, Mota A, Teixeira F.
    Transplant Proc; 2009 Apr 27; 41(3):868-73. PubMed ID: 19376375
    [Abstract] [Full Text] [Related]

  • 32. [The effect of an antioxidant tea polyphenols on cell apoptosis in rat model of cyclosporine-induced chronic nephrotoxicity].
    Shi S, Zheng S, Jia C, Zhu Y, Xie H.
    Zhonghua Wai Ke Za Zhi; 2002 Sep 27; 40(9):709-12. PubMed ID: 12411148
    [Abstract] [Full Text] [Related]

  • 33. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
    Demirjian S, Stephany B, Abu Romeh IS, Boumitri M, Yamani MH, Poggio ED.
    Clin Transplant; 2009 Sep 27; 23(3):351-60. PubMed ID: 19208105
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
    Brook NR, Waller JR, Bicknell GR, Nicholson ML.
    Transplant Proc; 2005 Sep 27; 37(1):130-3. PubMed ID: 15808571
    [Abstract] [Full Text] [Related]

  • 36. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
    Shihab F, Christians U, Smith L, Wellen JR, Kaplan B.
    Transpl Immunol; 2014 Jun 27; 31(1):22-32. PubMed ID: 24861504
    [Abstract] [Full Text] [Related]

  • 37. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1666-70. PubMed ID: 16854316
    [Abstract] [Full Text] [Related]

  • 38. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J, First MR, OPTIMA Study Group.
    Transplantation; 2008 Jul 15; 86(1):88-95. PubMed ID: 18622283
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial.
    Oberbauer R, Hutchison B, Eris J, Arias M, Claesson K, Mota A, Kreis H, Kleinman L, Wang F, Chen J, Revicki DA, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Apr 27; 75(8):1277-85. PubMed ID: 12717216
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.